Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Alzheimer Disease

1-anilino-8-naphthalenesulfonate has been researched along with Alzheimer Disease in 22 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research Excerpts

ExcerptRelevanceReference
"Obesity and type 2 diabetes mellitus are the most extended current chronic diseases and also Alzheimer pathology which is a progressive degenerative neurological disorder."1.62Inhibition of enzymes associated with metabolic and neurological disorder by dried pomegranate sheets as a function of pomegranate cultivar and fruit puree. ( Cano-Lamadrid, M; Carbonell-Barrachina, ÁA; Hernández, F; Lech, K; Nowicka, P; Tkacz, K; Turkiewicz, IP; Wojdyło, A, 2021)
"Alzheimer's disease is characterized in part by the accumulation of full-length tau proteins into intracellular filamentous inclusions."1.33Triggers of full-length tau aggregation: a role for partially folded intermediates. ( Chirita, CN; Congdon, EE; Kuret, J; Yin, H, 2005)

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.55)18.7374
1990's2 (9.09)18.2507
2000's6 (27.27)29.6817
2010's10 (45.45)24.3611
2020's3 (13.64)2.80

Authors

AuthorsStudies
Göransson, AL1
Nilsson, KP1
Kågedal, K1
Brorsson, AC1
Menden, A1
Hall, D1
Hahn-Townsend, C1
Broedlow, CA1
Joshi, U1
Pearson, A1
Crawford, F1
Evans, JE1
Klatt, N1
Crynen, S1
Mullan, M1
Ait-Ghezala, G1
Sanderson, JM1
Cano-Lamadrid, M1
Tkacz, K1
Turkiewicz, IP1
Nowicka, P1
Hernández, F1
Lech, K1
Carbonell-Barrachina, ÁA1
Wojdyło, A1
Wenzel, TJ1
Klegeris, A1
Yun, SM1
Park, JY1
Seo, SW1
Song, J1
Loli, H1
Narwal, SK1
Saun, NK1
Gupta, R1
Amin, N1
Jovanova, O1
Adams, HH1
Dehghan, A1
Kavousi, M1
Vernooij, MW1
Peeters, RP1
de Vrij, FM1
van der Lee, SJ1
van Rooij, JG1
van Leeuwen, EM1
Chaker, L1
Demirkan, A1
Hofman, A1
Brouwer, RW1
Kraaij, R1
Willems van Dijk, K1
Hankemeier, T1
van Ijcken, WF1
Uitterlinden, AG1
Niessen, WJ1
Franco, OH1
Kushner, SA1
Ikram, MA1
Tiemeier, H1
van Duijn, CM1
Laws, SM1
Eckart, K1
Friedrich, P1
Eisele, T1
Kurz, A1
Förstl, H1
Riemenschneider, M1
Du, J1
Wang, Z1
Xiao, Z1
Wang, J1
Chen, W2
Wang, P1
Zeng, H1
Burgess, BL1
McIsaac, SA1
Naus, KE1
Chan, JY1
Tansley, GH1
Yang, J1
Miao, F1
Ross, CJ1
van Eck, M1
Hayden, MR1
van Nostrand, W1
St George-Hyslop, P1
Westaway, D1
Wellington, CL1
Zhu, H1
Taylor, JW1
Bennett, DA1
Younkin, SG1
Estus, S1
Mahley, RW1
Ji, ZS1
Farooqui, AA2
Horrocks, LA2
Kallberg, Y1
Gustafsson, M1
Persson, B1
Thyberg, J1
Johansson, J1
Liss, L1
Koh, M1
Lee, H1
Lee, Y1
Lee, M1
Younan, ND1
Viles, JH1
Bolognesi, B1
Kumita, JR1
Barros, TP1
Esbjorner, EK1
Luheshi, LM1
Crowther, DC1
Wilson, MR1
Dobson, CM1
Favrin, G1
Yerbury, JJ1
Otzen, DE1
Miron, S1
Akke, M1
Oliveberg, M1
Chirita, CN1
Congdon, EE1
Yin, H1
Kuret, J1

Reviews

4 reviews available for 1-anilino-8-naphthalenesulfonate and Alzheimer Disease

ArticleYear
Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer's disease.
    Life sciences, 2018, Aug-15, Volume: 207

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Cathepsin B; Dinoprosto

2018
Lipases in Medicine: An Overview.
    Mini reviews in medicinal chemistry, 2015, Volume: 15, Issue:14

    Topics: Alzheimer Disease; Animals; Atherosclerosis; Cystic Fibrosis; Humans; Lipase; Medicine; Neoplasms; O

2015
Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E.
    Journal of lipid research, 1999, Volume: 40, Issue:1

    Topics: Alzheimer Disease; Animals; Apolipoproteins E; Biological Transport, Active; Cell Membrane; Chylomic

1999
Lipid peroxides in the free radical pathophysiology of brain diseases.
    Cellular and molecular neurobiology, 1998, Volume: 18, Issue:6

    Topics: Alzheimer Disease; Animals; Brain; Brain Diseases; Brain Ischemia; Down Syndrome; Free Radicals; Hum

1998

Other Studies

18 other studies available for 1-anilino-8-naphthalenesulfonate and Alzheimer Disease

ArticleYear
Identification of distinct physiochemical properties of toxic prefibrillar species formed by Aβ peptide variants.
    Biochemical and biophysical research communications, 2012, Apr-20, Volume: 420, Issue:4

    Topics: Acetates; Alzheimer Disease; Amyloid beta-Peptides; Anilino Naphthalenesulfonates; Cell Line; Fluore

2012
Exogenous lipase administration alters gut microbiota composition and ameliorates Alzheimer's disease-like pathology in APP/PS1 mice.
    Scientific reports, 2022, 03-21, Volume: 12, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Clostridiales; Disease Models, Animal; Gastrointe

2022
Far from Inert: Membrane Lipids Possess Intrinsic Reactivity That Has Consequences for Cell Biology.
    BioEssays : news and reviews in molecular, cellular and developmental biology, 2020, Volume: 42, Issue:3

    Topics: Acetyl-CoA Hydrolase; Acyl Coenzyme A; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Membr

2020
Inhibition of enzymes associated with metabolic and neurological disorder by dried pomegranate sheets as a function of pomegranate cultivar and fruit puree.
    Journal of the science of food and agriculture, 2021, Volume: 101, Issue:6

    Topics: Acetylcholinesterase; alpha-Amylases; alpha-Glucosidases; Alzheimer Disease; Butyrylcholinesterase;

2021
Association of plasma endothelial lipase levels on cognitive impairment.
    BMC psychiatry, 2019, 06-19, Volume: 19, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Brain; Cholesterol, HDL; Cognitive Dysfuncti

2019
Exome-sequencing in a large population-based study reveals a rare Asn396Ser variant in the LIPG gene associated with depressive symptoms.
    Molecular psychiatry, 2017, Volume: 22, Issue:4

    Topics: Adult; Alleles; Alzheimer Disease; Cholesterol, HDL; Depression; Depressive Disorder; Exome; Exons;

2017
No association of lipase C polymorphisms with Alzheimer's disease.
    Neurobiology of aging, 2010, Volume: 31, Issue:12

    Topics: Aged; Alzheimer Disease; Case-Control Studies; Female; Genetic Markers; Genetic Predisposition to Di

2010
Therapeutic potential of lipase inhibitor orlistat in Alzheimer's disease.
    Medical hypotheses, 2009, Volume: 73, Issue:5

    Topics: Alzheimer Disease; Enzyme Inhibitors; Humans; Lactones; Lipase; Models, Theoretical; Orlistat

2009
Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.
    Lipids in health and disease, 2012, Nov-26, Volume: 11

    Topics: Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Asian People; ATP Binding Cassette Transporter

2012
Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma.
    Neurobiology of disease, 2006, Volume: 24, Issue:1

    Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Blotting

2006
Lack of association of hepatic lipase polymorphisms with late-onset Alzheimer's disease.
    Neurobiology of aging, 2008, Volume: 29, Issue:5

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Genetic Predisposition to Disease; Humans; Lipas

2008
Prediction of amyloid fibril-forming proteins.
    The Journal of biological chemistry, 2001, Apr-20, Volume: 276, Issue:16

    Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid; Amyloid beta-Peptides; Animals; Candida; Databases,

2001
Stimulation of lipolytic enzymes in Alzheimer's disease.
    Annals of neurology, 1988, Volume: 23, Issue:3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Carboxylic Ester Hydrolases; Cell Membrane; Digly

1988
Characterization of early-stage amyloid aggregates by incorporating extrinsic fluorescence and atomic force microscopy.
    Journal of nanoscience and nanotechnology, 2014, Volume: 14, Issue:11

    Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid; Amyloid beta-Peptides; Anilino Naphthalenesulfonate

2014
A Comparison of Three Fluorophores for the Detection of Amyloid Fibers and Prefibrillar Oligomeric Assemblies. ThT (Thioflavin T); ANS (1-Anilinonaphthalene-8-sulfonic Acid); and bisANS (4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonic Acid).
    Biochemistry, 2015, Jul-21, Volume: 54, Issue:28

    Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid; Amyloid beta-Peptides; Anilino Naphthalenesulfonate

2015
ANS binding reveals common features of cytotoxic amyloid species.
    ACS chemical biology, 2010, Aug-20, Volume: 5, Issue:8

    Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Anilino Naphthalenesulfonates; Cell Line; Fluores

2010
Transient aggregation and stable dimerization induced by introducing an Alzheimer sequence into a water-soluble protein.
    Biochemistry, 2004, Oct-19, Volume: 43, Issue:41

    Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Anilino Naphthalenesulfonates; Dimeri

2004
Triggers of full-length tau aggregation: a role for partially folded intermediates.
    Biochemistry, 2005, Apr-19, Volume: 44, Issue:15

    Topics: Alzheimer Disease; Anilino Naphthalenesulfonates; Circular Dichroism; Fluorescent Dyes; Humans; In V

2005